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Purpose/Objective: Treatment planning and dose calculation are 
based on static images in radiotherapy. But some targets are subject 
to regular movements like breathing motion. Profile and magnitude of 
motion affect the applied dose leading to dose blurring. Taking into 
account motion during treatment, margins around the target are used 
to compensate motion induced effects on dose distributions. As 
magnitude of motion is patient specific, the associated margin has to 
be individual. The aim of this work is to analyze the effect on dose 
distributions. Parameters having an impact are amplitude and target 
size. Individual margins are investigated to compensate for motion 
induced dose blurring resulting in a better adapted treatment for each 
patient. 
Materials and Methods: Simulating different sized lung targets, 
Gafchromic EBT2 films (ISP, Wayne) are irradiated using a static 
thorax phantom. Different target and margin related field sizes are 
measured. Transmission of the film is determined with a flatbed 
scanner, evaluation and extraction of dose profiles are executed with 
MATLAB routines (R2011a, TheMathworks). The static dose profiles are 
blurred with MATLAB simulating breathing motion (symmetric cos4 
function) with peak-to-peak-amplitudes in the range of 0-30 mm in 
the direction of the profile. The target region of the profile is 
analysed in static and motion case each having various margins. Mean 
dose and EUD of the target region are calculated for several target 
sizes and compared for different combinations of motion amplitudes 
and margins. 
Results: In figure 1, EUD of the target region as function of the 
applied margin is shown for different motion amplitudes. Data are 
normalized to the value without motion and margin. For a moving 
target, EUD and mean dose decrease with increasing motion 
amplitude. Magnitude of this effect depends on the target size, 
additionally. To reach the same EUD and mean dose in case of motion 
as in static case, a margin has to be applied. Thus EUD and mean dose 
increase for all amplitudes and target sizes, but not in the same ratio. 
For growing target size the margin decreases for a constant 
amplitude, because the shape of the field edges change with size. 
Therefore, individual margins have to be determined considering 
individual motion amplitude and target size. 
  
Figure 1: EUD of the target region as function of the applied margin 
for different motion amplitudes. 
 
Conclusions: Individual margins are important applying the treatment 
best possible for each patient. To compensate for motion effects, the 
margin must depend not only on motion amplitude but also on target 
size. In the future, a mathematical correlation is quested for to 
calculate an individual margin for known motion amplitude and target 
size.  
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Purpose/Objective: The injection of a polyethylen glycol spacer (PGS) 
in the Denonvilliers fascia aiming to separate the prostate from the 
anterior rectal wall has been recently introduced for curative 
radiotherapy (RT) delivered to patients with localized prostate 
cancer. Sparing of the rectum from the high RT doses with PGS will be 
achieved and a decrease of radiation-induced toxicities is awaited. In 
this study we assessed the impact of PGS in the interfraction prostate 
motion in patients undergoing curative RT for prostate cancer. 
Materials and Methods: Twenty patients with (n=10) or without 
(n=10) PGS were treated to the prostate ± seminal vesicles according 
to a hypofractionated RT protocol (14x4 Gy, twice/thrice-a-week). All 
patients were implanted with three fiducial markers (FM) before the 
start of RT and underwent between 4 to 8 cone-beam computed 
tomography (CBCT) scans during the RT course. Constant bladder and 
rectal filling was controlled by proper patient instruction and, if 
necessary, using rectal enemas before every RT fraction. Relative 
displacements between the prostate isocenter based on the FM's 
position and the bony anatomy were quantified in the LR (left-right), 
AP (anterior-posterior), SI (superior-inferior) axes for every patient by 
offline analyses of CBCTs. A total of 122 CBCTs were evaluated. 
Systematic (Σ) and random (σ) setup errors were determined and 
planning target volumes (PTV) margins computed with the Van Herk 
formula (= 2.5 Σ + 0.7 σ). 
Results: The overall mean errors and the average of the standard 
deviations of the prostate displacements during the RT course were -
0.03 and 0.67 mm, 0.35 and 1.60 mm, and -0.26 mm and 1.56 mm for 
the LR, AP, and SI axes, respectively. A mean interfraction motion ≥ 4 
mm was observed in LR, AP, and SI directions in 0, 3 (15%), and 2 
(10%) patients, respectively. Mean prostate interfraction movements 
in patients treated with or without PGS were 0.32 mm vs. -0.38 mm, 
0.12 mm vs. 0.59 mm and -0.36 mm vs. -0.17 mm in the LR, AP and SI 
directions, respectively. Despite an overall prostate motion less 
marked of 0.44 mm in the AP direction for patients with PGS, the Σ 
and σ errors remained similar for both groups in the three axes. 
Estimated PTV margins using a CBCT-based bony alignment were 
similar for patients treated with or without a PGS implant, requiring 
1.97 mm vs. 2.11 mm, 8.92 mm vs. 8.55 and 7.19 mm vs. 6.63 mm for 
the LR, AP and SI axes, respectively. 
Conclusions: The implant of PGS does not significantly influence the 
interfraction prostate motion in patients treated with curative RT for 
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prostate cancer. The major expected benefit of PGS should be a 
reduction of the high-dose levels to the rectal wall, rather than a 
prostate spatial fixation by-standing effect. 
   
EP-1262   
Dosimetric impact of poor compliance with full-bladder protocol for 
prostate patients on Tomotherapy 
G. Webster1, M. Tiffany1, G. Sangha1, C. Bode2, P. Massey2, J. 
Cashmore1, A. Zarkar3 
1Hall Edwards Research Group University Hospital Birmingham NHS 
Foundation Trust, Medical Physics, Birmingham, United Kingdom  
2Hall Edwards Research Group University Hospital Birmingham NHS 
Foundation Trust, Radiotherapy, Birmingham, United Kingdom  
3Hall Edwards Research Group University Hospital Birmingham NHS 
Foundation Trust, Oncology, Birmingham, United Kingdom  
 
Purpose/Objective: Prostate patients at our hospital are treated to 
74Gy using a full-bladder drinking protocol, which is intended to 
improve seminal vesicle stability and reduce dose to bowel and 
bladder. Tomotherapy Planned Adaptive (TomoPA) permits dose 
distribution evaluation using daily MVCT imaging and is frequently 
used to assess the dosimetric impact of subjectively-defined 
incompliance with the drinking protocol. To optimise the clinical 
workflow, a simple, consistent method is needed to identify situations 
in which plan adaptation may be required. 
Materials and Methods: For each of 6 prostate patients receiving 
Tomotherapy,selected due to poor compliance with drinking protocol, 
4 MVCT scans showing large reductions in bladder volume were 
transferred to TomoPA. Bladder and bowel were contoured on the 
MVCT and the dose distribution recalculated. Compliance with 
PIVOTAL Trial protocol constraints was quantified. A single observer 
investigated various potential metrics (i.e. absolute and relative 
reductions in (i) bladder volume and (ii)bladder extension superior to 
prostate apex) to determine the optimal criteria for referral to 
TomoPA. 
Results: 5/24 MVCT scans were rejected due to limited scan length 
rendering identification of relevant bladder and bowel unreliable. In 
the remaining 19 scans, the lower dose PIVOTAL bowel constraints 
(i.e. V45<158cc,V50<110cc, V55<28cc) were always met, regardless of 
bladder volume reduction, while higher dose constraints (i.e. 
V60<6cc, V65=0cc) were exceeded only twice, in the same patient. 
‘Mandatory’ bladder tolerances (i.e.V65<50%, V70<30%) were 
exceeded in only 2/19 instances, although failure to meet ‘optimal’ 
constraints (V50<50%, V60<25%, V70<5%) was widespread in this 
cohort. The 1cm PTV margins adequately enclosed the seminal 
vesicles (>56.2Gy) in all cases. No metric consistently predicted 
dosimetric impact, although>50% bladder volume reduction from 
initial planning CT appeared to coincide with sharp increases in dose 
for both bowel (see figure) and bladder. Bladder volume could be 
measured for this purpose with an abdominal ultrasound probe prior 
to the patient entering the treatment room. Potential use of linear 
change in bladder extension, (ruler measurement on the MVCT image) 
as a predictive metric that would be easily identifiable prior to 
treatment and require minimal additional time, warrants further 
study, although the current cohort did not demonstrate a strong 
correlation in this regard. 
 
  
Conclusions: Tomotherapy prostate plans appear robust to large 
bladder volume changes, with dosimetric tolerances exceeded in only 
a few extreme cases. A bladder volume reduction >50% suggests that 
dosimetric evaluation may be warranted, although confirmation on a 
larger cohort is required prior to clinical implementation. 
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Purpose/Objective: The purpose of this study is to evaluate an offline 
adaptive IGRT protocol. Kilovoltage cone-beam CTs (CBCT) acquired 
during the first radiotherapy treatment sessions were used to adapt 
the PTV individually to variable organ filling and variation in 
positioning. Variation in rectum dose was studied. 
Materials and Methods: Eighteen patients post-prostatectomy with 
biochemical or macroscopic relapse in the prostate bed and two 
patients with localized prostate cancer, who underwent primary 3D 
conformal radiotherapy, were evaluated. The patients received 66.6 
to 76.2Gy (1.8Gy x 5weekly). All patients started radiotherapy with a 
4 field box technique to at least 18Gy. Then the treatment was 
continued with a VMAT technique on either the same or the modified 
PTV. The kV-CBCTs acquired in the first three fractions were 
transferred to the planning systems (Masterplan, Nucletron 
Netherlands and Eclipse, Varian Palo Alto CA) and registered with the 
planning CT. The rectum was delineated in all CBCTs (from below 
sigmoid flexure to above anal verge) and transferred to the planning 
CT. The PTV was adapted taking significant variation in organ filling 
and positioning into account. For planning CT and CBCTs V35 and V60 
(volume of organ in % that achieved 35Gy or 60Gy) for rectum were 
evaluated. The maximum dose to femoral head and femoral neck 
were evaluated in the planning CT. The modification of the PTV was 
estimated. 
Results: Variability of rectum during radiotherapy treatment 
influences the final administered rectum dose in comparison to 
planning CT and may influence the PTV. After the evaluation of the 
CBCTs, the PTV was modified for 15 of 20 patients. The changes of 
PTV had a range of 82 to -31cm³. Four PTVs were enlarged and nine 
reduced. The mean change of volume was 21cm³ with a standard 
deviation of 20cm³. In the planning CT the mean V35 for rectum over 
all patients was 52% with a standard deviation of 11%. The mean 
individual changes of V35 in planning CT and CBCTs for the rectum 
were 39 to 80% with a standard deviation of 1 to 13%. The maximal 
dose to femoral heads was 42Gy with a standard deviation of 9Gy. 
Conclusions: An evaluation of rectum volumes in the CBCTs of the 
first IGRT treatments results in a more realistic estimation of rectal 
dose and makes an adaptation of the PTV to individual variability in 
organ fillings and positioning uncertainties feasible. Commencing 
prostate treatments with a box technique and changing to a VMAT 
technique, after the PTV modification, is less time-consuming and still 
enables constrains for organs at risk to be fulfilled. 
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Purpose/Objective: To evaluate the need to correct full daily 
variation in patient anatomy and set-up when intensity-modulated 
radiotherapy (IMRT) is delivered in prostate and head and neck cancer 
patients with the Protura 6 DOF robotic couch (CIVCO Medical 
Solution). 
Materials and Methods: Prostate and H&N cancer patients treated 
with IMRT were selected for this study. Before starting radiation 
treatment each patient underwent a CT scan for radiotherapy 
planning. Prostate cancer patients were simulated in supine position 
with the dual leg CIVCO support system; conventional thermoplastic 
masks were used for immobilization of H&N patients. All patients 
received a daily CBCT before treatment to display the patient position 
and to detect necessary corrections. Geometrical shifts (3-Traslational 
and 3-Rotational) were identified by manual and/or automatic 3D 
match (Varian 6D Online Review System) and were then applied to the 
Protura 6 DOF robotic couch and recorded. Mean translational and 
rotational corrections and the/a 3D vector of displacement were 
calculated. 
Results: From October to December 2012, 5 prostate and 3 H&N 
patients were included in this ongoing study. One hundred and sixty 
CBCT studies were analyzed and compared. The mean (±SD) 
interfraction displacement of the translational corrections for 
prostate vs H&N patients were -0.2 ± 0.3 vs 0,1 ± 0,2 cm, 0.0 ± 0.3 vs 
0,2 ± 0,2 cm and -0.2 ± 0.5 vs 0,0 ± 0,3 cm in vertical, lateral and 
longitudinal direction. We observed a maximal translation shift (MTS) 
